FORT LAUDERDALE, Fla., Dec. 14 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc. reported that that the CT Laser Mammography (CTLM(R)) system was officially introduced to the Polish medical community and public at the opening ceremonies of the Center of Prophylactic and Early Cancer Diagnosis at the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology on November 16th, 2005, in Gliwice, Poland.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )
Professor Boguslaw Maciejewski, MD, PhD, FACR, Director of the Institute of Oncology, began the day-long program with a press conference featuring a panel of oncology physicians and industry leaders. The panel stressed the capabilities of the Polish Institute of Oncology, especially the Gliwice Branch, which was recently updated with the latest innovations. Panel member Tim Hansen, IDSI Chief Executive Officer, spoke about the CTLM system’s advanced technologies. The interview was followed by a public grand opening conference and ceremony featuring the panel members.
Hosted tours of the Center highlighted many cutting-edge modalities. Several ribbon-cutting ceremonies unveiled advances in MRI imaging, radiation treatment planning, ultrasound, and CT Laser Mammography, among others.
“The Institute of Oncology is our premiere reference site in Europe, featuring two CTLM systems and a significant patient caseload,” commented Hansen. “They have completed over 1,500 laser mammography patient studies and serve over 7 million people in their region. Our partnership with the Institute enables us to explore routine diagnostic CTLM imaging as well as applications in oncology. Our research areas involve innovative studies, such as CTLM applicability to estimation of tumor regression rates and local tumor clearance, as well as correlations between CTLM and mammography images with molecular biomarkers. Through our collaboration, we are gaining valuable insights; we look forward to seeing the Center publish their findings.”
The ceremony and CTLM debut was broadcast on television and radio stations throughout Poland, along with interviews with Professor Maciejewski that discussed breast studies and new diagnostic and screening capabilities in the Gliwice region. An educational program on new techniques in breast imaging, highlighting the CTLM system, is also being developed, with the help of EDOMED, IDSI’s exclusive distributor in Poland. The 30-minute program is scheduled to air on December 22nd on Poland’s national television station, TVP1.
The Institute of Oncology, a Comprehensive Cancer Center, has been registered by the Organization of European Cancer Institutes (O.E.C.I.) as a European Comprehensive Cancer Centre of Excellence since 2002.
The CTLM(R) system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000-13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.
Please visit Imaging Diagnostic Systems’ website at: http://www.imds.com for additional information.
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company’s filing with the Securities Exchange Commission.
Investor Relations: Rick Lutz 404-261-1196 lcgroup@mindspring.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comImaging Diagnostic Systems, Inc.
CONTACT: Rick Lutz, +1-404-261-1196, or lcgroup@mindspring.com, for IMDS
Web site: http://www.imds.com/